 |
About Us
Breakthrough technology for real-time monitoring
of the metabolic state of the patient and as a novel endpoint of resuscitation
Critisense's first generation product - the "CritiView"
is an innovative patient monitoring system providing real-time continuous
information via four physiological parameters, sensed at the tissue
level, reflecting the systemic metabolic state.
CritiView is the only device providing continuous, real-time multi-parametric
physiological data at the tissue and cellular level, by monitoring
the mitochondrial function and the microcirculatory blood flow and
oxygen saturation.
CritiView is an adjunctive monitor which provides:
| a. |
Early identification/warning of the body’s critical metabolic imbalances
or tissue viability of a patient. |
| b. |
End point of resuscitation.
| - |
These early warning changes are in advance of current critical care
monitors capabilities to detect physiological changes
at the tissue level. |
| - |
Thus allowing the clinician to make more refined corrective medical
actions. |
To become the market
leader in monitoring the metabolic
state of the patient in critical care settings, by continuous,
real-time direct assessment of tissue Viability
using "CritiView"
as a diagnostic tool. |
|
|
